Stamatina Zavitsanou

ORCID: 0000-0003-1637-4456
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Diabetes Management and Research
  • Pancreatic function and diabetes
  • Diabetes and associated disorders
  • Advanced Control Systems Optimization
  • Wireless Body Area Networks
  • Hyperglycemia and glycemic control in critically ill and hospitalized patients
  • Diabetes Treatment and Management
  • Diet, Metabolism, and Disease
  • Smart Grid Energy Management
  • Food composition and properties
  • Consumer Attitudes and Food Labeling
  • Field-Flow Fractionation Techniques
  • Nutrition, Genetics, and Disease
  • Intravenous Infusion Technology and Safety
  • Optimal Experimental Design Methods
  • IoT and Edge/Fog Computing

Harvard University
2016-2019

Sansum Diabetes Research Institute
2017-2019

Imperial College London
2011-2015

The development of artificial pancreas (AP) technology for deployment in low-energy, embedded devices is contingent upon selecting an efficient control algorithm regulating glucose people with type 1 diabetes mellitus. In this paper, we aim to lower the energy consumption AP by reducing controller updates, that is, number times decision-making invoked compute appropriate insulin dose.Physiological insights into management are leveraged design event-triggered model predictive (MPC) operates...

10.1109/tbme.2017.2707344 article EN IEEE Transactions on Biomedical Engineering 2017-05-23

There is an unmet need for a modular artificial pancreas (AP) system clinical trials within the existing regulatory framework to further AP research projects from both academia and industry. We designed, developed, tested interoperable (iAPS) smartphone app that can interface wirelessly with leading continuous glucose monitors (CGM), insulin pump devices, decision-making algorithms while running on unlocked smartphone.After algorithm verification, hazard mitigation analysis, complete...

10.1089/dia.2018.0278 article EN Diabetes Technology & Therapeutics 2018-12-14

Abstract Background Postbariatric hypoglycemia (PBH) can threaten safety and reduce quality of life. Current therapies are incompletely effective. Methods Patients with PBH were enrolled in a double-blind, placebo-controlled, crossover trial to evaluate closed-loop glucose-responsive automated glucagon delivery system designed severe hypoglycemia. A detection mitigation algorithm was embedded the artificial pancreas connected continuous glucose monitor (CGM, Dexcom) driving patch infusion...

10.1210/clinem/dgz197 article EN The Journal of Clinical Endocrinology & Metabolism 2019-11-12

Significant increases in processing power, coupled with the miniaturization of units operating at low power levels, has motivated embedding modern control systems into medical devices. The design such embedded decision-making strategies for applications is driven by multiple crucial factors, as: (i) guaranteed safety presence exogenous disturbances and unexpected system failures; (ii) constraints on computing resources; (iii) portability longevity terms size consumption; (iv) manufacturing...

10.3390/pr4040035 article EN Processes 2016-09-23

This study presents a general closed-loop control strategy for optimal insulin delivery in type 1 Diabetes Mellitus (T1DM). The proposed aims toward an individualized that consists of patient-specific model predictive controller, state estimator, personalized scheduling level, and open-loop optimization problem subjected to process constraints. can be also modified address the case limited patient data availability resulting "approximation" strategy. Both strategies are validated silico...

10.1109/tbme.2015.2427991 article EN IEEE Transactions on Biomedical Engineering 2015-04-29

Background: Food choices are essential to successful glycemic control for people with diabetes. We compared the impact of three carbohydrate-rich meals on postprandial response in adults type 1 diabetes (T1D). Methods: performed a randomized crossover study 12 T1D (age 58.7 ± 14.2 years, baseline hemoglobin A1c 7.5% 1.3%) comparing using continuous glucose monitoring: (1) "higher protein" pasta containing 10 g protein/serving, (2) regular 7 and (3) extra-long grain white rice. All contained...

10.1089/dia.2019.0109 article EN Diabetes Technology & Therapeutics 2019-06-21

While artificial pancreas (AP) systems are expected to improve the quality of life among people with type 1 diabetes mellitus (T1DM), design convenient that optimize user experience, especially for those active lifestyles, such as children and adolescents, still remains an open research question. In this work, we introduce embeddable implementation model predictive control (MPC) AP T1DM significantly reduces weight on-body footprint system. The controller is based on a zone MPC has been...

10.1109/tcst.2019.2939122 article EN IEEE Transactions on Control Systems Technology 2019-09-18

Embedded or wearable artificial pancreas (AP) systems must be capable of low energy operation to ameliorate battery depletion and reduce the need for frequent recharge cycles. One major contributors drain such embedded AP is power utilized wireless communication among components AP: continuous glucose monitor (CGM), control module, insulin pump, mobile app display. In this paper, an event-triggered (ETC) algorithm proposed reducing sensor-to-controller transmissions. Concretely, a CGM value...

10.1109/ccta.2017.8062517 article EN 2021 IEEE Conference on Control Technology and Applications (CCTA) 2017-08-01

Background: Continuous glucose monitoring (CGM) systems are increasingly becoming essential components in type 1 diabetes mellitus (T1DM) management. Current CGM technology requires frequent calibration to ensure accurate sensor performance. The accuracy of these is great importance since medical decisions made based on monitored values and trends. Methods: In this work, we introduce a strategy that augmented with weekly updating feature. During the life cycle sensor, mechanism periodically...

10.1177/1932296817734367 article EN Journal of Diabetes Science and Technology 2017-10-16

An essential component in the design of a wearable or implantable artificial pancreas is low-power, embedded control algorithm capable tight glucose regulation people with Type 1 Diabetes Mellitus (T1DM). In this paper, physiological insights into management are leveraged to formulate safety-constrained, event-triggered model predictive (MPC) customized reduce number controller updates, leading reduced processor runtime and lowered energy expenditure. The proposed MPC deployed on (65 mm × 30...

10.23919/acc.2017.7962943 article EN 2022 American Control Conference (ACC) 2017-05-01

Current therapies for post-bariatric hypoglycemia (PBH) are incompletely effective. We previously reported feasibility of an open-loop glucagon system this challenging syndrome. In study, patients with PBH were enrolled in a double-masked, placebo-controlled, crossover trial to determine the efficacy closed-loop mini-dose delivery reduce severe after mixed meal. A novel detection & mitigation algorithm was embedded Artificial Pancreas System connected continuous glucose monitor (CGM, Dexcom)...

10.1210/js.2019-or22-3 article EN cc-by-nc-nd Journal of the Endocrine Society 2019-04-01

Background: Food choices are essential to successful glycemic control in persons with diabetes. Methods: Twelve adults type 1 diabetes (T1D) (age 58.7±14.2 years, HbA1c 7.5±1.3%) completed an in-clinic double-blinded crossover study comparing the response higher protein pasta (10 grams protein/serving), regular (7 and white rice. All meals contained 42 carbohydrate, were served homemade tomato sauce, green salad balsamic dressing, repeated random order. Linear mixed effects models assessed 5...

10.2337/db19-779-p article EN Diabetes 2019-06-01
Coming Soon ...